The 28-day survive for critically ill cancer patients undergoing continuous renal replacement with postoperative acute kidney injure: a retrospective study of 86 cases
Abstract:Background: Advances in oncology led to a substantial increase in the number of patients requiring admission to the intensive care unit (ICU). It remains controversial to start continuous renal replacement therapy (CRRT) for acute kidney injure (AKI) in critically ill patients with cancer because of the poor outcome and high costs. Methods: In this retrospective study, we collected data from patients with cancer with postoperative AKIstage 3 [Kidney Disease: Improving Global Outcomes (KDIGO), 2012] undergoing … Show more
“…Several studies demonstrated that whether solid tumor or hematological malignancy patients, the prognosis of AKI was related to disease severity and AKI grading, but not cancer staging (28)(29)(30)(31). Critically ill cancer patients with AKI who received renal replacement therapy had similar short-term outcomes compared with AKI patients without cancer (29).…”
Section: Question 4 How Is the Prognosis Of Critically Ill Cancer Patients With Acute Kidney Injury?mentioning
“…Several studies demonstrated that whether solid tumor or hematological malignancy patients, the prognosis of AKI was related to disease severity and AKI grading, but not cancer staging (28)(29)(30)(31). Critically ill cancer patients with AKI who received renal replacement therapy had similar short-term outcomes compared with AKI patients without cancer (29).…”
Section: Question 4 How Is the Prognosis Of Critically Ill Cancer Patients With Acute Kidney Injury?mentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.